Skip to main content
SpringerLink
Log in

Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung ADHS) im Erwachsenenalter

  • Chapter
Psychiatrie und Psychotherapie

  • 11k Accesses

Zusammenfassung

Die ADHS, die gekennzeichnet ist durch eine situationsübergreifende Störung der Aufmerksamkeit und der Impulskontrolle sowie durch motorische Hyperaktivität, desorganisiertes Verhalten und eine Störung der Affektkontrolle galt lange Zeit als eine Erkrankung des Kindes- und Jugendalters. Die Pr ä valenz für diese Altersgruppe wird anhand einer US-Untersuchung an einer repräsentativen Bevölkerungsstichprobe mit 7% angegeben (Bloom u. Dey 2006). Daten aus Langzeitverlaufsstudien, in denen Kinder mit ADHS bis ins Erwachsenenalter beobachtet wurden, konnten zeigen, dass bei einem Teil der betroffenen Kinder die Symptomatik auch im Erwachsenenalter weiter besteht (Mannuzza et al. 1998). ADHS wird daher zunehmend verstanden als eine chronische, lebenslange Störung.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 199.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Adler LA, Resnik S, Kunz M, Devinsky O (1995) Open-label trial of venlafaxine in adults with attention-deficit-disorder. Psychopharmacol Bull 31: 785–788

    PubMed  CAS  Google Scholar 

  • Adler LA, Spencer T, Reimherr F et al. (2003) Efficacy and safety of atomoxetine in long-term open label treatment of adults with ADHD. Poster presented during the APA annual meeting, San Francisco

    Google Scholar 

  • APA (2000) American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn, revised. American Psychiatric Press, Washington/DC

    Google Scholar 

  • Banaschewski T, Brandeis D, Heinrich H et al. (2003) Association of ADHD and conduct disorder — brain electrical evidence for the existence of a distinct subtype. J Child Psychol Psychiatry 44: 356–376

    PubMed  Google Scholar 

  • Barkley RA (1997) Behavioural inhibition, sustained attention and executive functions. Constructing a unifying theory of ADHD. Psychol Bull 121: 65–94

    PubMed  CAS  Google Scholar 

  • Barkley RA (2002) Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry 63: 10–15

    PubMed  Google Scholar 

  • Barkley RA, Biederman J (1997) Toward a broader definition of the age-of-onset criterion for attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 36: 1204–1210

    PubMed  CAS  Google Scholar 

  • Barkley RA, Murphy KR, Dupaul GI, Bush T (2002) Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes and the role of executive functioning. J Int Neuropsychol Soc 8: 655–672

    PubMed  Google Scholar 

  • Bartlik B, Harmon G (1997) Use of methylphenidate in a patient with glaucoma and attention deficit disorder: a clinical dilemma. Arch Gen Psychiatry 54: 188–189

    PubMed  CAS  Google Scholar 

  • Bemporad JR (2001) Aspects of psychotherapy with adults with attention deficit disorder. Ann NY Acad Sci 931: 302–309

    PubMed  CAS  Google Scholar 

  • Berquin PC, Giedd JN, Jacobson LK et al. (1998) Cerebellum in attention deficit/hyperactivity disorder. Neurology 50: 1087–1093

    PubMed  CAS  Google Scholar 

  • Biederman J (2004) Impact of comorbidity in adults with attention-deficit/hyperactivity disorder J Clin Psychiatry 65(Suppl 3): 3–7

    PubMed  Google Scholar 

  • Biederman J (2005) Attention-deficit/hyperactivity disorder: a selective overview. Biol Psychiatry 57: 1215–1220

    PubMed  Google Scholar 

  • Biederman J, Spencer T (2002) Methylphenidate in treatment of adults with attention deficit/hyperactivity disorder. J Atten Disord 6: 101–107

    Google Scholar 

  • Biederman J, Faraone SV, Spencer T et al. (1993) Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 150: 1792–1798

    PubMed  CAS  Google Scholar 

  • Biederman J, Wilens T, Mick E et al. (1999) Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 104: e20

    PubMed  CAS  Google Scholar 

  • Biederman J, Mick E, Faraone SV (2000) Age-dependent decline of symptoms of attention-deficit hyperactivity disorder: impact of remission, definition and symptom type. Am J Psychiatry 157: 816–818

    PubMed  CAS  Google Scholar 

  • Biederman J, Mick E, Faraone SV et al. (2002) Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry 159: 36–42

    PubMed  Google Scholar 

  • Biederman J, Faraone SV, Monuteaux M et al. (2004) Gender effects of attention deficit hyperactivitiy disorder in adults, revised. Biol Psychiatry 55: 692–700

    PubMed  Google Scholar 

  • Biederman J, Monuteaux MC, Mick E et al. (2006) Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study Psychol Med 36: 167–179

    PubMed  Google Scholar 

  • Bloom B, Dey AN (2006) Summary health statistics for U.S. children: National Health Interview Survey 2004. Vital Health Stat 10(227): 1–85

    Google Scholar 

  • Brown TE (2004) Atomoxetine and stimulants in combination for treatment of attention deficit hyperactivity disorder: four case reports. J Child Adolesc Psychopharmacol 14: 129–136

    PubMed  Google Scholar 

  • Brown TE, McMullen WJ (2001) Attention deficit disorders and sleep/arousal disturbance. Ann NY Acad Sci 931: 271–286

    PubMed  CAS  Google Scholar 

  • Bush G, Frazier JA, Rauch SL (1999) Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the counting stroop. Biol Psychiatry 45: 1542–1552

    PubMed  CAS  Google Scholar 

  • Castellanos F, Giedd J, Marsh W et al. (2001) Quantitative brain magnetic resonance imaging in girls with attention deficit/hyperactivity disorder. Arch Gen Psychiatry 58: 289–295

    PubMed  CAS  Google Scholar 

  • Cheon KA, Ryu YH, Kim YK et al. (2003) Dopamine transporter density in the basal ganglia assessed with (123)IPT SPECT in children with attention deficit hyperactivity disorder. Eur J Nucl Med Mol Imaging 30: 306–311

    PubMed  CAS  Google Scholar 

  • Colla M, Heuser I (2005) Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter. In Holsboer F, Gründer, Benkert O (Hrsg) Handbuch der psychiatrischen Pharmakotherapie. Springer, Wien New York

    Google Scholar 

  • Comings DE, Gade-Andavolu R, Gonzalez N et al. (2000) Comparison of the role of dopamine, serotonin and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin Genet 57: 178–196

    PubMed  CAS  Google Scholar 

  • Comings DE, Gonzalez NS, Cheng Li, Mac Murray J (2003) A line »item« approach to the identification to the identification of genes involved in polygenic behavioural disorders: the adrenergic alpha2A (ADRA2A) gen. Am J Med Genet 118B: 110–114

    PubMed  CAS  Google Scholar 

  • Cox DJ, Merkel RL, Kovatchev B, Seward R (2000) Effect on stimulant medication on driving performance of young adults with attention deficit hyperactivity disorder: a preliminary double-blind placebo controlled trial. J Nerv Ment Dis 188: 230–234

    PubMed  CAS  Google Scholar 

  • Curran S, Mill J, Tahir E et al. (2001) Association study of a dopamine transporter polymorphism and attention deficit hyperactivity disorder in UK and Turkish samples. Mol Psychiatry 6: 425–428

    PubMed  CAS  Google Scholar 

  • Davids E (2005) Psychostimulanzien und weitere Medikamente zur Behandlung der ADHS und Hypersomnien. In Benkert O, Hippius (Hrsg) Kompendium der psychiatrischen Pharmakotherapie, 5. Aufl. Springer, Berlin Heidelberg New York

    Google Scholar 

  • De Luca V, Muglia P, Vincent J et al. (2004) Adrenergic alpha 2C receptor genomic organization: Association study in adult ADHD. Am J Med Genet 127B: 65–67

    PubMed  Google Scholar 

  • Diehl A, Sobanski E, Severa L et al. (2004) Alkoholabhängigkeit bei Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS): Rückfallschutz oder Suchtverlagerung durch Methylphenidat ? Poster. 15. Wissenschaftliche Tagung der Deutschen Gesellschaft für Suchtforschung und Suchttherapie e.V.

    Google Scholar 

  • Dilling H, Mombour W, Schmidt MH (Hrsg) (1991) Internationale Klassifikation psychischer Storungen. ICD-10, Kapitel V (F). Klinische diagnostische Leitlinien, 2. Aufl. Huber, Bern

    Google Scholar 

  • Ding YS, Fowler JS, Volkow ND et al. (1997) Chiral drugs: Comparison of the pharmacocinetics of [11C] d-threo and L-threo-methylphenidate in the human and baboon brain. Psychopharmacology 131: 71–78

    PubMed  CAS  Google Scholar 

  • Dorrego MF, Canevaro L, Kuzis G et al. (2002) A randomized, doubleblind, cross-over study of methylphenidtae and lithium in adults with attention deficit hyperactivity disorder. J Neuropsychiatry Clin Neurosci 14: 289–293

    PubMed  CAS  Google Scholar 

  • Dougherty DD, Bonab AA, Spencer TJ et al. (1999) Dopamine transporter density is elevated in patients with ADHD. Lancet 354: 2132–2133

    PubMed  CAS  Google Scholar 

  • Dresel S, Krause J, Krause KH et al. (2000) Attention deficit hyperactivity disorder: Binding of [99mTc] TRODAT-1 to the dopamine transporter before and after methylphenidate treatment. Eur J Nucl Med 27: 1518–1524

    PubMed  CAS  Google Scholar 

  • Eakin L, Minde K, Hechtman L et al. (2004) The martial and family functioning of adults with ADHD and their spouses. J Atten Disord 8: 1–10

    PubMed  CAS  Google Scholar 

  • Ebert D, Krause J, Roth-Sackenheim C (2003) ADHS im Erwachsenenalter — Leitlinien auf der Basis eines Expertenkonsensus mit Unterstutzung der DGPPN. Nervenarzt 10: 939–946

    Google Scholar 

  • Ernst M, Kimes AS, London ED et al. (2003) Neural substrates of decision making in adults with attention-deficit/hyperactivity disorder. Am J Psychiatry 53: 871–8788

    Google Scholar 

  • Faraone SV, Biederman J (2005) What is the Prevalence of adult ADHD? Results of a population screen of 966 adults J Atten Disord 9: 384–391

    PubMed  Google Scholar 

  • Faraone SV, Wilens T (2003) Does stimulant treatment lead to substance use disorder? J Clin Psychiatry 64: 9–13

    PubMed  CAS  Google Scholar 

  • Faraone SV, Biederman J, Spencer T (2000) Attention-deficit/hyperactivity disorder in adults: an overview. Biol Psychiatry 48: 9–20

    PubMed  CAS  Google Scholar 

  • Faraone SV, Spencer T, Aleardi M et al. (2004) Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit-hyperactivity disorder. J Clin Psychopharmacol 24: 24–29

    PubMed  CAS  Google Scholar 

  • Faraone SV, Perlis RH, Doyle AE et al. (2005) Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57: 1313–1323

    PubMed  CAS  Google Scholar 

  • Fossati A, Novella L, Donati D et al. (2002) History of childhood attention deficit/hyperactivity disorder symptoms and borderline personality disorder: a controlled study. Compr Psychiatry 43: 369–377

    PubMed  Google Scholar 

  • Fung YK, Lau YS (1989) Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems. Pharmacol Biochem Behav 33: 1–6

    PubMed  CAS  Google Scholar 

  • Garrettson LK, Perel JM, Dyton PG (1969) Methylphenidate interaction with both anticonvulsants and ethyl biscoumacetate. JAMA 207: 2053–2056

    PubMed  CAS  Google Scholar 

  • Heiligenstein E, Conyers LM, Berns AR, Miller MA (1998) Preliminary normative data on DSM-IV attention deficit hyperactivitiy disorder in college students. J Am Coll Health 46: 213

    Google Scholar 

  • Hervey AS, Eppstein JN, Curry JF (2004) Neuropsychology of Adults with Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review. Neuropsychology 18: 485–503

    PubMed  Google Scholar 

  • Hesslinger B, Tebartz van Elst L, Thiel T (2002 a) Fronto-orbital volume reductions in adult patients with attention-deficit/hyperactivity disorder. Neurosci Lett 328: 319–321

    PubMed  CAS  Google Scholar 

  • Hesslinger B, Tebartz van Elst L, Nyberg E et al. (2002 b) Psychotherapy of attention deficit hyperactivity disorder in adults: a pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci 252: 177–184

    PubMed  Google Scholar 

  • Hesslinger B, Tebartz van Elst L, Mochan F, Ebert D (2003 a) Attention deficit hyperactivity disorder in adults — early vs. late onset in a retrospective study. Psychiatry Research 119: 217–223

    PubMed  Google Scholar 

  • Hesslinger B, Tebartz van Elst L, Mochan F, Ebert D (2003 b) A psychological study into the relationship between attention deficit hyperactivity disorder in adult patients and recurrent brief depression. Acta Psychiatr Scand 107: 321–322

    Google Scholar 

  • Hesslinger B, Philipsen A, Richter H, Ebert D (2004) Psychotherapie der ADHS im Erwachsenenalter. Ein Arbeitsbuch. Hogrefe, Göttingen

    Google Scholar 

  • Huss M (2004) Langzeiteffekte der Stimulanzientherapie. In: Schulte-Markwort M, Warnke A (Hrsg) Methylphenidat. Thieme, Stuttgart New York

    Google Scholar 

  • Kessler RC, Adler L, Ames M et al. (2005 a) The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 35: 245–256

    PubMed  Google Scholar 

  • Kessler RC, Chiu WT, Demler O, Walters E (2005 b) Prevalence, severity and comorbidity of 12-Month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617–627

    PubMed  Google Scholar 

  • Kessler RC, Adler L, Barkley R et al. (2006) The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry 163: 716–723

    PubMed  Google Scholar 

  • Krause J, Krause KH (2005) ADHS im Erwachsenenalter, 2. Aufl. Schattauer, Stuttgart New York

    Google Scholar 

  • Krause KH, Dressel SH, Krause J et al. (2003) The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci Biobehav Rev 27: 605–613

    PubMed  CAS  Google Scholar 

  • Kuperman S, Perry PJ, Gaffney GR et al. (2001) Bupropion vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Ann Clin Psychiatry 13: 129–134

    PubMed  CAS  Google Scholar 

  • Leonard BE, McCartan D, White J, King DJ (2004) Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol Clin Exp 19: 151–180

    CAS  Google Scholar 

  • Levin FR, Evans SM, McDowell D et al. (1997) Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry 59: 300–305

    Google Scholar 

  • Mannuzza S, Klein RG (2000) Long-term prognosis in attention-deficit/hyperactivity disorder. Child adolesc Psychiatr Clin N Am 9: 711–726

    PubMed  CAS  Google Scholar 

  • Mannuzza S, Klein RG, Bessler A et al. (1998) Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 155: 493–498

    PubMed  CAS  Google Scholar 

  • Markowitz JS, Patrick KS (2001) Pharmacokinetic and pharmakodynamic drug interactions in the treatment of attention deficit hyperactivity disorder. Clin Pharmacokinet 40: 753–772

    PubMed  CAS  Google Scholar 

  • Marks DJ, Newcorn JH, Halperin JM (2001) Comorbidity in adults with attention deficit hyperactivity disorder. Ann NY Acad Sci 931: 216–238

    Article  PubMed  CAS  Google Scholar 

  • McEvoy B, Hawi Z, Fitzgerald M, Gill M (2002) No evidence of linkage or association between the norepinephrine transporter (NET) geme polymprphism and ADHD in the Irish population. Am J Med Genet 114: 665–666

    PubMed  Google Scholar 

  • McGough JJ, Barkley RA (2004) Diagnostic controversies in adult ADHD. Am J Psych 161: 1948–56

    Google Scholar 

  • McGough, Smalley SL, McCracken JT et al. (2005) Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings form multiplex families. Am J Psychiatry 162: 1621–1627

    PubMed  Google Scholar 

  • Michelson D, Allen A, Busner J et al. (2002) Once-daily atomoxetine treatment for children and adolescents with attention-deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 159: 1896–1901

    PubMed  Google Scholar 

  • Michelson D, Adler L, Spencer T et al. (2003) Atomoxetin in adults with ADHD: Two randomized, placebo-controlled studies. Biol Psychiatry 53: 112–120

    PubMed  CAS  Google Scholar 

  • Mick E, Biederman J, Prince J et al. (2002) Impact of low birth weight on attention-deficit/hyperactivity disorder. J Dev Behav Pediatr 23: 16–22

    PubMed  Google Scholar 

  • Mick E, Faraone SV, Biederman J (2004) Age-dependent expression of attention deficit hyperactivity disorder symptoms. Psychiatr Clin N Am 27: 215–224

    Google Scholar 

  • Millberger S, Biederman J, Faraone SV et al. (1996) Is maternal smoking during pregnancy a risk factor for attention deficit hyperactivity disorder in children. Am J Psychiatry 153: 1138–1141

    Google Scholar 

  • Murphy K (2005) Psychosocial treatments for ADHD in teens and adults: a practice-friendly review. J Clin Psychol 61: 607–619

    PubMed  Google Scholar 

  • Murphy KR, Barkley RA (1996 a) Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: implications for clinical diagnosis. J Atten Disord 1: 174–161

    Google Scholar 

  • Murphy KR, Barkley RA (1996 b) Attention deficit hyperactivity disorder in adults: comorbidities and adaptive impairments. Compr Psychiatry 37: 393–401

    PubMed  CAS  Google Scholar 

  • Murray C, Johnston C (2006) Parenting in mothers with and without attention-deficit/hyperactivity disorder J Abnorm Psychol 115: 52–61

    PubMed  Google Scholar 

  • Nierenberg AA, Miyahara S, Sprencer T et al. (2005) Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000STEP-BD participants. Biol Psychiatry 57: 1467–1473

    PubMed  Google Scholar 

  • Paterson R, Douglas C, Hallmayer J et al. (1999) A randomised, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Aust N Z J Psychiatry 33: 494–502

    PubMed  CAS  Google Scholar 

  • Philipsen A, Feige B, Hesslinger B et al. (2005) Sleep in adults with attention-deficit attention/hyperactivity disorder: a controlled polysomnographic study including spectral analysis of the sleep EEG. Sleep 28: 738–745

    Google Scholar 

  • Philipsen A, Richter H, Peters J et al. (2007) Efficacy of a structured group psychotherapy in adults with attention-deficit-hyperactivity disorder-results of a multicenter study. J Nerv Ment Disease (in press)

    Google Scholar 

  • Rasmussen P, Gillberg C (2000) Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry 39: 1424–1431

    PubMed  CAS  Google Scholar 

  • Retz W, Retz-Junginger P, Hengesch G et al. (2004) Psychometric and psychopathological characterization of young male prison inmates with and without attention deficit/hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 254: 201–208

    PubMed  Google Scholar 

  • Retz-Junginger P, Retz W, Blocher D et al. (2002) Wender Utah Rating Scale (WURS-K). Die deutsche Kurzform zur retrospektiven Erfassung des hyperkinetischen Syndroms bei Erwachsenen. Nervenarzt 73: 830–838

    PubMed  CAS  Google Scholar 

  • Roman T, Schmitz M, Polanczyk GV et al. (2003) is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention deficit hyperactivity disorder? Am J Med Gent 120B: 116–120

    Google Scholar 

  • Rösler M, Retz W, Retz-Junginger P et al. (2004) Instrumente zur Diagnostik der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS) im Erwachsenenalter. Selbstbeurteilungsskala (ADHS-SB) und Diagnosecheckliste (ADHS-DS). Nervenarzt 75: 778–795

    Google Scholar 

  • Rösler M, Retz-Junginger P, Retz W, Stieglitz R-D (2007) Skalen zur Diagnostik der adulten Aufmerksamkeitsdefizit/Hyperaktivitätsstörung (SKADAA). Hogrefe, Göttingen

    Google Scholar 

  • Rubia K, Overmeyer S, Taylor E et al. (1999) Functional frontalisation with age: mapping neurodevelopmental trajectories with fMRI. Neurosci Biobehav Rev 24: 13–19

    Google Scholar 

  • Sachs GS, Baldassano CF, Truman CJ (2000) Comorbidity of attention deficit disorder with early-and late-onset bipolar disorder Am J Psychiatry 157: 466–468

    PubMed  CAS  Google Scholar 

  • Safren SA, Otto MW, Sprich S (2005 a) Cognitive behavioural therapy of ADHD in medication-treated adults with continued symptoms. Behav Res Ther 43: 831–842

    PubMed  Google Scholar 

  • Safren SA, Perlman CA, Sprich S, Otto MW (2005 b) Mastering your adult ADHD: a cognitive behavioural treatment program. Oxford University Press, Oxford New York

    Google Scholar 

  • Schubiner H, Saules KK, Arfken CL et al. (2002) Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 10: 286–294

    PubMed  CAS  Google Scholar 

  • Schweitzer JB, Faber TL, Grafton ST et al. (2000) Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. Am J Psychiatry 157(2). 278–280

    PubMed  CAS  Google Scholar 

  • Seidman LJ (2006) Neuropsychological functioning in people with ADHD across the lifespan. Clin Psychol Rev 26: 466–485

    PubMed  Google Scholar 

  • Seidman LJ, Valera EM, Bush G (2004) Brain function and structure in adults with attention-deficit/hyperactivity disorder. Psychiatr Clin N Am 27: 323–347

    Google Scholar 

  • Sergeant JA (2000) The cognitive-energetic model: an empirical approach to ADHD. Neurosci Biobehav Rev 24: 7–12

    PubMed  CAS  Google Scholar 

  • Sergeant JA (2005) Modeling attention-deficit/hyperactivity disorder: a critical appraisal of the cognitive-energetic model. Biol Psychiatry 57: 1248–1255

    PubMed  Google Scholar 

  • Sobanski E (2006) Psychiatric comorbidity in adults with attention deficit hyperactivity disorder. Eur Arch Psychiatry Clin Neurosci 256(Suppl 1): 26–31

    Google Scholar 

  • Sobanski E, Alm B (2004) Aufmerksamkeitsdefizit/Hyperaktivitätsstörung (ADHS) bei Erwachsenen. Nervenarzt 75: 697–715

    PubMed  CAS  Google Scholar 

  • Sobanski E, Alm B (2005) Oros-MPH: Eine Alternative in der medikamentosen Behandlung erwachsener Patienten mit ADHS. Nervenarzt 76: 1412–1415

    PubMed  CAS  Google Scholar 

  • Sobanski E, Alm B, Krumm B (2007) Methylphenidatbehandlung bei erwachsenen Patienten mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS): Bedeutung von Störungssubtyp und psychiatrischer Komorbidität. Nervenarzt 78: 328–337

    PubMed  CAS  Google Scholar 

  • Sonuga-Barke EJS (2005) Causal models of ADHD: from common simple deficits to multiple developmental pathways. Biol Psychiatry 57: 1231–1238

    PubMed  Google Scholar 

  • Spencer T, Wilens TE, Biederman SV et al. (1995) A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder. Arch Gen Psychiatry 52: 434–443

    PubMed  CAS  Google Scholar 

  • Spencer T, Biederman J, Wilens T et al. (1998) Effectivness and tolerability of tomoxetine in adults with attention-deficit hyperactivity disorder. Am J Psychiatry 155: 693–695

    PubMed  CAS  Google Scholar 

  • Spencer T, Biederman J, Wilens T (1999) Attention-deficit/hyperactivity disorder and comorbidity. Pediatric Clin N Am 46: 915–927

    CAS  Google Scholar 

  • Spencer T, Biederman J, Wilens T et al. (2001) Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 58: 784–785

    Google Scholar 

  • Spencer T, Biederman J, Wilens T et al. (2005) A large double-blind, randomized trial of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorder. Biol Psychiatry 57: 456–463

    PubMed  CAS  Google Scholar 

  • Sprich-Buckminster S, Biederman J, Millberger S et al. (1993) Are perinatal complications relevant to the manifestation of ADD? Issues of comorbidity and familiality. J Am Acad Child Adolesc Psychiatry 32: 1032–1037

    PubMed  CAS  Google Scholar 

  • Stevenson CS, Whitmont S, Bornholt L et al. (2002) A cognitive remediation program for adults with attention deficit hyperactivity disorder. Aust NZ J Psychiatry 36: 610–616

    Google Scholar 

  • Strohbeck-Kuhner P, Sobanski E, Skopp G et al. (2006) ADHS und Fahreignung. Z Verkehrssicherheit 1: 18–22

    Google Scholar 

  • Surman CB, Thomas RJ, Aleardi M et al. (2006) Adults with ADHD and sleep complaints: a pilot study identifying sleep-disordered breathing using polysomnography and sleep quality assessment. J Atten Disord 9: 550–555

    PubMed  Google Scholar 

  • Taylor FB (2000) Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit disorder in adults. J Child Adolesc Psychopharmacol 10: 311–320

    PubMed  CAS  Google Scholar 

  • Taylor FB, Russo J (2001) Comparing guanfacine and dextroamphetamine for the treatment of adult attention deficit hyperactivity disorder. J Clin Psychopharmacol 21: 223–228

    PubMed  CAS  Google Scholar 

  • Turner DC, Clark L, Dowson J et al. (2004) Modafinil improves cognition and response inhibition in adults with attention deficit hyperactivity disorder. Biol Psychiatry 55: 1031–1040

    PubMed  CAS  Google Scholar 

  • Vaidya CJ, Austin G, Kirkorian G. et al. (1998) Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci USA 95: 14494–14499

    PubMed  CAS  Google Scholar 

  • Van De Kamp J, Collins A (1994) Prenatal nicotine alters nicotinic receptor development in the mouse brain. Pharmacol Biochem Behav 47: 889–900

    PubMed  Google Scholar 

  • Van de Meere J, Vreeling HJ, Segeant J (1992) A motor presetting study in hyperactive, learning disabled and control children. J Child Psychol Psychiatry 33: 1347–1354

    PubMed  Google Scholar 

  • Walitza S, Seifert J, Warnke A, Gerlach M (2004) Psychostimulanzien In Gerlach M, Warnke A, Wewetzer C (Hrsg) Neuropsychopharmaka im Kindes-und Jugendalter. Springer, Wien New York

    Google Scholar 

  • Warnke A, Walitza S (2004) Methylphenidat in der Behandlung der Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung (ADHS). In Schulte-Markwort M, Warnke A (Hrsg) Methylphenidat. Thieme, Stuttgart New York

    Google Scholar 

  • Weiss MD, Weiss JR (2004) A Guide to the treatment of adults with ADHD. J Clinical Psychiatry 65(Suppl 3): 27–37

    Google Scholar 

  • Wender PH, Reimherr FW (1990) Bupropion treatment of attention deficit hyperactivity disorder in adults. Am J Psychiatry 147: 1018–1120

    PubMed  CAS  Google Scholar 

  • Wender PH, Reimherr FW, Wood DR (1981) Attention Deficit Disorder (‚Minimal Brain Dysfunction in Adults’). A replication study of diagnosis and treatment. Arch Gen Psychiatry 38: 449–456

    PubMed  CAS  Google Scholar 

  • Wender PH, Reimherr FW, Wood DR et al. (1985) A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type in adults. Am J Psychiatry 142: 547–552

    PubMed  CAS  Google Scholar 

  • Wender PH, Wolf LE, Wasserstein J (2001) Adults with ADHD. an overview. Ann NY Acad Sci 931: 1–16

    PubMed  CAS  Google Scholar 

  • Wernicke JF et al. (2002) Safety profile of atomoxetine in the treatment of children and adolescents with ADHD. J Clin Psychiatry 63: 50–55

    PubMed  CAS  Google Scholar 

  • Wilens TE, Biederman J, Prince J et al. (1996) Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 153: 1147–1153

    PubMed  CAS  Google Scholar 

  • Wilens TE, Biederman J, Spencer TJ et al. (1999) A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry 156: 1931–1937

    PubMed  CAS  Google Scholar 

  • Wilens TE, Spencer TJ, Biederman J et al. (2001) A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 158: 282–288

    PubMed  CAS  Google Scholar 

  • Wilens TE, Faraone SV, Biederman J et al. (2003) Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111: 179–185

    PubMed  Google Scholar 

  • Wilens TE (2004) Impact of ADHD and its treatment on substance abuse in adults. J Clin Psychiatry 65(Suppl 3): 38–47

    PubMed  Google Scholar 

  • Wilens TE, Hammerness PG, Biederman J et al. (2005 a) Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry 66: 253–259

    Article  PubMed  Google Scholar 

  • Wilens TE, Haight BR, Horrigan JP et al. (2005 b) Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled trial. Biol Psychiatry 57: 793–801

    PubMed  CAS  Google Scholar 

  • Wouldes T, LaGasse L, Sheridan J, Sesier B (2004) Maternal methamphetamine use during pregnancy and child outcome: What do we know? NZ Med J 117: U 1180

    Google Scholar 

  • Zametkin AJ, Nordahl TH, Gross M (1990) Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 323: 1361–1366

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Zentralinstitut für Seelische Gesundheit J5, 68159, Mannheim

    Frau Dr. B. Alm & Frau Dr. E. Sobanski

Authors
  1. Frau Dr. B. Alm
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frau Dr. E. Sobanski
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum der Ludwig-Maximilians-Universität München, Nußbaumstr. 7, 80336, München

    Hans-Jürgen Möller

  2. Inn-Salzach-Klinikum Wasserburg a. Inn · Rosenheim · Freilassing Fachkrankenhaus für Psychiatrie, Psychotherapie, Psychosomatische Medizin und Neurologie Akademisches Lehrkrankenhaus, Ludwig-Maximilians-Universität München, Gabersee 7, 83512, Wasserburg am Inn

    Gerd Laux

  3. Klinik für Psychiatrie, Medizinische Universität Graz, Auenbruggerplatz 31, 8036, Graz, Österreich

    Hans-Peter Kapfhammer

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Alm, B., Sobanski, E. (2008). Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung ADHS) im Erwachsenenalter. In: Möller, HJ., Laux, G., Kapfhammer, HP. (eds) Psychiatrie und Psychotherapie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-33129-2_64

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-33129-2_64

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-24583-4

  • Online ISBN: 978-3-540-33129-2

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation